Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:36:47.305Z.
Calculation as of: 2026-10-06T19:36:47.305Z.
Quote observation: 2026-10-06T19:35:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Generate Biomedicines, Inc.
Market Cap
$1.78B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.75B
Free Cash Flow Yield
10.69%
TTM Avg
10.17%
3Y Avg
6.99%
5Y Avg
4.97%
Market Cap
$1.81B
Free Cash Flow Yield
N/A
TTM Avg
5.11%
3Y Avg
5.11%
5Y Avg
5.11%
Market Cap
$1.81B
Free Cash Flow Yield
4.08%
TTM Avg
3.25%
3Y Avg
2.36%
5Y Avg
2.43%
Market Cap
$1.74B
Free Cash Flow Yield
N/A
TTM Avg
0.77%
3Y Avg
2.10%
5Y Avg
2.10%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.78B | N/A | N/A | N/A | N/A |
| Xencor, Inc. (XNCR)vs › | $1.78B | N/A | 2.44% | 2.95% | 2.88% |
| Absci Corporation (ABSI)vs › | $1.76B | N/A | N/A | N/A | N/A |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 10.69% | 10.17% | 6.99% | 4.97% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.81B | N/A | 5.11% | 5.11% | 5.11% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 4.08% | 3.25% | 2.36% | 2.43% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | N/A | 0.77% | 2.10% | 2.10% |
| Novavax, Inc. (NVAX)vs › | $1.82B | N/A | 4.74% | 3.25% | 3.25% |
| Novocure Ltd (NVCR)vs › | $1.74B | N/A | 0.29% | 0.49% | 0.42% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 8.67% | 8.12% | 5.35% | 4.67% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
